{"id":2,"date":"2022-11-11T15:20:09","date_gmt":"2022-11-11T19:20:09","guid":{"rendered":"https:\/\/knighttx.com\/?page_id=2"},"modified":"2026-10-11T11:45:00","modified_gmt":"2026-10-11T15:45:00","slug":"home","status":"publish","type":"page","link":"https:\/\/knighttx.com\/fr\/","title":{"rendered":"Home"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"2\" class=\"elementor elementor-2\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-ca4b2e0 elementor-section-height-min-height elementor-section-items-top elementor-section-content-top elementor-section-boxed elementor-section-height-default\" data-id=\"ca4b2e0\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-no\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-a6163bf\" data-id=\"a6163bf\" data-element_type=\"column\" data-e-type=\"column\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-a78d3ad elementor-invisible elementor-widget elementor-widget-heading\" data-id=\"a78d3ad\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;_animation&quot;:&quot;fadeIn&quot;,&quot;_animation_delay&quot;:0}\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">B\u00e2tir une compagnie pharmaceutique chef de file pour le Canada et l'Am\u00e9rique latine<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-66 elementor-top-column elementor-element elementor-element-a8aebd4\" data-id=\"a8aebd4\" data-element_type=\"column\" data-e-type=\"column\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-3eea0e8 elementor-invisible elementor-widget elementor-widget-image\" data-id=\"3eea0e8\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;_animation&quot;:&quot;fadeInRight&quot;}\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/knighttx.com\/images-global\/banner-topo2024.png\" title=\"\" alt=\"\" loading=\"lazy\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-e030ab5 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"e030ab5\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-cdc69ce\" data-id=\"cdc69ce\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-3faf153 elementor-widget elementor-widget-heading\" data-id=\"3faf153\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">Nouvelles<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-0c32cf1 elementor-hidden-desktop elementor-hidden-tablet elementor-hidden-mobile elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"0c32cf1\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-933cfa5\" data-id=\"933cfa5\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-8cad5bc elementor-widget elementor-widget-text-editor\" data-id=\"8cad5bc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div id=\"list-item-details-container-3375375\" class=\"list-item-details-container\"><div class=\"list-item-details-reading-date\"><div id=\"list-item-details-container-3375375\" class=\"list-item-details-container\"><div class=\"list-item-details-reading-date\"><span id=\"list-item-content-date-3375375\" class=\"list-item-content-date\">October 06, 2026 07:35 ET<\/span><\/div><span class=\"source-section\"><label class=\"source-separator mr-1\">|<\/label><label class=\"label-source\">Source:<\/label><a class=\"organization-name\" href=\"https:\/\/www.globenewswire.com\/en\/search\/organization\/Knight%2520Therapeutics\" data-autid=\"organization-name\">Th\u00e9rapeutique Knight inc.<\/a><\/span><\/div><a id=\"list-item-content-title-3375375\" class=\"list-item-content-title\" href=\"https:\/\/www.globenewswire.com\/news-release\/2026\/10\/06\/3375375\/0\/fr\/th%C3%A9rapeutique-knight-annonce-l-approbation-r%C3%A9glementaire-de-niktimvo-au-br%C3%A9sil.html\" target=\"_self\">Th\u00e9rapeutique Knight annonce l\u2019approbation r\u00e9glementaire de NIKTIMVO\u00ae au Br\u00e9sil<\/a><div id=\"list-item-content-body-3375375\" class=\"list-item-content-body\">MONTR\u00c9AL, 06 oct. 2026 (GLOBE NEWSWIRE) &#8212; Th\u00e9rapeutique Knight inc. (TSX : GUD) (\u00ab Knight \u00bb), soci\u00e9t\u00e9 pharmaceutique panam\u00e9ricaine (hors \u00c9tats-Unis), a annonc\u00e9 aujourd\u2019hui avoir re\u00e7u une&#8230;<\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a2d125b elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"a2d125b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9798935 elementor-widget elementor-widget-text-editor\" data-id=\"9798935\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div id=\"list-item-details-container-3375365\" class=\"list-item-details-container\"><div class=\"list-item-details-reading-date\"><span id=\"list-item-content-date-3375365\" class=\"list-item-content-date\">October 06, 2026 07:30 ET<\/span><\/div><span class=\"source-section\"><label class=\"source-separator mr-1\">|<\/label><label class=\"label-source\">Source:<\/label><a class=\"organization-name\" href=\"https:\/\/www.globenewswire.com\/en\/search\/organization\/Knight%2520Therapeutics\" data-autid=\"organization-name\">Th\u00e9rapeutique Knight inc.<\/a><\/span><\/div><p><a id=\"list-item-content-title-3375365\" class=\"list-item-content-title\" href=\"https:\/\/www.globenewswire.com\/news-release\/2026\/10\/06\/3375365\/0\/fr\/th%C3%A9rapeutique-knight-annonce-le-lancement-de-tavalisse-au-br%C3%A9sil.html\" target=\"_self\">Th\u00e9rapeutique Knight annonce le lancement de TAVALISSE\u00ae au Br\u00e9sil<\/a><\/p><div id=\"list-item-content-body-3375365\" class=\"list-item-content-body\">MONTR\u00c9AL, 06 oct. 2026 (GLOBE NEWSWIRE) &#8212; Th\u00e9rapeutique Knight inc. (TSX : GUD) (\u00ab Knight \u00bb), soci\u00e9t\u00e9 pharmaceutique panam\u00e9ricaine (hors \u00c9tats-Unis), a annonc\u00e9 aujourd\u2019hui le lancement de&#8230;<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-509051c elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"509051c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-02b1150 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"02b1150\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-62a36fa\" data-id=\"62a36fa\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-0f1e01a elementor-widget elementor-widget-feedzy-rss-feeds\" data-id=\"0f1e01a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"feedzy-rss-feeds.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"feedzy-aa946c74caaff58e7ee490401a363547 feedzy-rss\">\n\t\t<ul class=\"feedzy-default\">\n\t\t\t\t\t<li  style=\"padding: 15px 0 25px\" class=\"rss_item feedzy-rss-col-1\" >\n\t\t\t\t\t\t\t\t\t<span class=\"title\">\n\t\t\t\t\t\t<a href=\"https:\/\/www.globenewswire.com\/news-release\/2026\/10\/06\/3375375\/0\/fr\/th%C3%A9rapeutique-knight-annonce-l-approbation-r%C3%A9glementaire-de-niktimvo-au-br%C3%A9sil.html\" target=\"_blank\"  rel=\"noopener nofollow\">\n\t\t\t\t\t\t\tTh\u00e9rapeutique Knight annonce l\u2019approbation r\u00e9glementaire de NIKTIMVO\u00ae au Br\u00e9sil\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<div class=\"rss_content\"\n\t\t\t\t\t\tstyle=\"\">\n\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>MONTR\u00c9AL,  06 oct. 2026  (GLOBE NEWSWIRE) -- Th\u00e9rapeutique Knight inc. (TSX : GUD) (\u00ab Knight \u00bb), soci\u00e9t\u00e9 pharmaceutique panam\u00e9ricaine (hors \u00c9tats-Unis), a annonc\u00e9 aujourd\u2019hui avoir re\u00e7u une autorisation r\u00e9glementaire acc\u00e9l\u00e9r\u00e9e, dans le cadre de la voie r\u00e9glementaire de ANVISA pour les maladies rares, pour NIKTIMVO\u00ae [&hellip;]<\/p>\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/li>\n\t\t\t\t\t\t<li  style=\"padding: 15px 0 25px\" class=\"rss_item feedzy-rss-col-1\" >\n\t\t\t\t\t\t\t\t\t<span class=\"title\">\n\t\t\t\t\t\t<a href=\"https:\/\/www.globenewswire.com\/news-release\/2026\/10\/06\/3375365\/0\/fr\/th%C3%A9rapeutique-knight-annonce-le-lancement-de-tavalisse-au-br%C3%A9sil.html\" target=\"_blank\"  rel=\"noopener nofollow\">\n\t\t\t\t\t\t\tTh\u00e9rapeutique Knight annonce le lancement de TAVALISSE\u00ae au Br\u00e9sil\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<div class=\"rss_content\"\n\t\t\t\t\t\tstyle=\"\">\n\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>MONTR\u00c9AL,  06 oct. 2026  (GLOBE NEWSWIRE) -- Th\u00e9rapeutique Knight inc. (TSX : GUD) (\u00ab Knight \u00bb), soci\u00e9t\u00e9 pharmaceutique panam\u00e9ricaine (hors \u00c9tats-Unis), a annonc\u00e9 aujourd\u2019hui le lancement de TAVALISSE\u00ae (fostamatinib disodique hexahydrat\u00e9) au Br\u00e9sil, pour le traitement des patients adultes atteints de thrombocytop\u00e9nie immunitaire [&hellip;]<\/p>\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/li>\n\t\t\t\t<\/ul>\n<\/div>\n<style type=\"text\/css\" media=\"all\">.feedzy-rss .rss_item .rss_image{float:left;position:relative;border:none;text-decoration:none;max-width:100%}.feedzy-rss .rss_item .rss_image span{display:inline-block;position:absolute;width:100%;height:100%;background-position:50%;background-size:cover}.feedzy-rss .rss_item .rss_image{margin:.3em 1em 0 0;content-visibility:auto}.feedzy-rss ul{list-style:none}.feedzy-rss ul li{display:inline-block}<\/style>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c502bf4 elementor-widget elementor-widget-spacer\" data-id=\"c502bf4\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-a69fb2d elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"a69fb2d\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-2a3201f\" data-id=\"2a3201f\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-95c9352 elementor-align-center elementor-hidden-tablet elementor-widget elementor-widget-button\" data-id=\"95c9352\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm elementor-animation-grow\" href=\"https:\/\/investors.knighttx.com\/French\/nouvelles\/default.aspx\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Voir plus <\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-b64ba3c elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"b64ba3c\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-44d788c\" data-id=\"44d788c\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-c3d9146 elementor-widget elementor-widget-spacer\" data-id=\"c3d9146\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>B\u00e2tir une compagnie pharmaceutique chef de file pour le Canada et l&#8217;Am\u00e9rique latine Nouvelles October 06, 2026 07:35 ET|Source:Th\u00e9rapeutique Knight inc.Th\u00e9rapeutique Knight annonce l\u2019approbation r\u00e9glementaire de NIKTIMVO\u00ae au Br\u00e9silMONTR\u00c9AL, 06 oct. 2026 (GLOBE NEWSWIRE) &#8212; Th\u00e9rapeutique Knight inc. (TSX : GUD) (\u00ab Knight \u00bb), soci\u00e9t\u00e9 pharmaceutique panam\u00e9ricaine (hors \u00c9tats-Unis), a annonc\u00e9 aujourd\u2019hui avoir re\u00e7u une&#8230; [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"footnotes":""},"class_list":["post-2","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/knighttx.com\/fr\/wp-json\/wp\/v2\/pages\/2","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/knighttx.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/knighttx.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/knighttx.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/knighttx.com\/fr\/wp-json\/wp\/v2\/comments?post=2"}],"version-history":[{"count":509,"href":"https:\/\/knighttx.com\/fr\/wp-json\/wp\/v2\/pages\/2\/revisions"}],"predecessor-version":[{"id":79725,"href":"https:\/\/knighttx.com\/fr\/wp-json\/wp\/v2\/pages\/2\/revisions\/79725"}],"wp:attachment":[{"href":"https:\/\/knighttx.com\/fr\/wp-json\/wp\/v2\/media?parent=2"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}